Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeBlog › Beyond-Use Dates

Journal · Updated 2026-08-11

Beyond-Use Dates: Why Compounded GLP-1s Expire in Weeks, Not Years

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

The short answer

Brand pens carry manufacturer expiration dates measured in years because industrial production validates long stability. Compounded vials carry a beyond-use date (BUD) — assigned by the pharmacy under USP sterile-compounding standards (chapter 797, with 795 governing nonsterile) — typically measured in weeks, because a pharmacy-prepared sterile product's assurance window is limited by its preparation category, testing, and storage conditions, not by the peptide's theoretical chemistry alone. The operating rules: the label's BUD and storage terms are the product's specification — a multi-dose compounded vial is commonly dated weeks out under refrigeration, whatever the marketing said about supply; the clock and the conditions travel together (a BUD assumes the labeled storage — a warm afternoon doesn't extend it); and past-BUD product is discarded, full stop — degradation and contamination are invisible, peptides fail without cloudiness, and "it looks fine" is not a sterility test.

Why the window is short, and how to live with it

The BUD encodes two separate risks. Sterility: every needle puncture of a multi-dose vial is an event; USP's framework limits how long a compounded sterile preparation may be used based on how and where it was made and whether sterility testing supported a longer date — which is why asking a pharmacy how its BUDs are assigned (default categories versus product-specific testing) is a legitimate quality question our vetting checklist includes. Stability: peptides degrade with time, temperature, light, and agitation — potency drifts before anything visible changes, and a degraded dose is an under-dose with a false label. Living with short windows is logistics: match order quantity to the BUD (a "three-month supply" in one vial dated six weeks out is a math error someone should have caught — and a question worth asking before purchase), refrigerate per the storage guide, date the vial's first puncture, and build the reorder cadence around the printed date rather than the marketing month. The comparison shoppers should hold: brand products' year-scale dating and sealed single-use formats are part of what the price premium buys — the brand-versus-compounded math counts it fairly, and so should you.

Questions people ask

How long does compounded semaglutide or tirzepatide last?

Until its beyond-use date — assigned by the pharmacy under USP sterile-compounding standards, typically weeks out under refrigeration, printed on the label. The BUD, not any marketing 'monthly supply' language, is the product's real shelf life, and it assumes the labeled storage conditions throughout.

Can I use a compounded GLP-1 past its BUD if it looks clear?

No — potency loss and contamination are invisible; peptides degrade without cloudiness, and sterility can't be eyeballed. Past-BUD product is discarded. If your supply keeps outliving its dates, fix the ordering cadence, not the discard rule.

Why does my vial expire before my 'month supply' runs out?

That mismatch is worth raising with the pharmacy before purchase: quantity should match the BUD. It happens when marketing describes supply in months while the label dates the vial in weeks — the label wins, and a pharmacy's answer to 'how are your BUDs assigned?' is a quality signal our vetting checklist scores.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.